Latest Health News
Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods
BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian…
InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
December 12, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
Extendicare Announces December 2025 Dividend of C$0.042 per Share
December 12, 2025 17:00 ET | Source: Extendicare Inc. MARKHAM, Ontario, Dec.…
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025 16:30 ET | Source: Zevra Therapeutics CELEBRATION, Fla., Dec.…
Teva Releases Q4 2025 Aide Memoire
December 12, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
Accelerating Patient Recruitment and Research Excellence: TrialWire Supports Endpoints Clinical Trials Day NYC 2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest,…
Genesis Healthcare Remains Committed to Securing Longterm Stability
KENNETT SQUARE, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Following a court…
